Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1164/rccm.201512-2319ED | DOI Listing |
J Cell Biol
November 2023
Center for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, Baltimore, MD, USA.
The transmembrane serine protease matriptase is a key regulator of both barrier-disruptive and protective epithelial cell-cell interactions. Elevated matriptase is a consistent feature of epithelial ovarian cancers (OvCa), where multicellular spheroids shed from the primary tumor into the peritoneal cavity are critical drivers of metastasis. Dynamic cell-to-cell adhesive contacts are required for spheroid formation and maintenance.
View Article and Find Full Text PDFIUBMB Life
June 2023
Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Biomed Res Int
October 2022
Department of Oral Biochemistry, And Institute of Biomaterials-Implant, College of Dentistry, Wonkwang University, Iksan City, Jeonbuk 54538, Republic of Korea.
Matriptases are cell surface proteolytic enzymes belonging to the type II transmembrane serine protease family that mediate inflammatory skin disorders and cancer progression. Matriptases may affect the development of periodontitis via protease-activated receptor-2 activity. However, the cellular mechanism by which matriptases are involved in periodontitis is unknown.
View Article and Find Full Text PDFSci Rep
December 2021
Nordic Bioscience, Immunoscience, Biomarkers and Research, Herlev, Denmark.
Osteoarthritis (OA) and rheumatoid arthritis (RA) are serious and painful diseases. Protease-activated receptor 2 (PAR2) is involved in the pathology of both OA and RA including roles in synovial hyperplasia, cartilage destruction, osteophyogenesis and pain. PAR2 is activated via cleavage of its N-terminus by serine proteases.
View Article and Find Full Text PDFOncol Rep
December 2021
Department of Oral Biochemistry, School of Dentistry, Wonkwang University, Iksan, Jeollabuk 570‑749, Republic of Korea.
Matriptases, members of the type II transmembrane serine protease family, are cell surface proteolytic enzymes that mediate tumor invasion and metastasis. Matriptase is highly expressed in breast cancer and is associated with poor patient outcome. However, the cellular mechanism by which matriptase mediates breast cancer invasion remains unknown.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!